Aspira Womens Health Inc AWH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $3.43
- Day Range
- $3.31–3.68
- 52-Week Range
- $2.31–6.75
- Bid/Ask
- $3.35 / $3.39
- Market Cap
- $34.94 Mil
- Volume/Avg
- 7,707 / 31,113
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.90
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. The Company markets and sells, 1) Ova1, a blood test intended as an aid to assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical and radiological evaluation does not indicate malignancy; (2) Overa, a second-generation biomarker reflex intended to maintain Ova1’s high sensitivity while improving specificity; (3) Ova1Plus, a reflex offering which uses Ova1 as the primary test and Overa as a confirmation for Ova1 intermediate range results; and (4) OvaWatch, a lab-developed blood test intended to assist in the initial clinical assessment of malignancy risk in all women with an adnexal mass.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 85
- Website
- https://www.aspirawh.com
Valuation
Metric
|
AWH
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 2.90 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
AWH
|
---|---|
Quick Ratio | 1.30 |
Current Ratio | 1.47 |
Interest Coverage | — |
Quick Ratio
AWH
Profitability
Metric
|
AWH
|
---|---|
Return on Assets (Normalized) | −127.94% |
Return on Equity (Normalized) | −497.42% |
Return on Invested Capital (Normalized) | −269.94% |
Return on Assets
AWH
Diagnostics & Research Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Mmmqpbhlst | Kvdnl | $220.9 Bil | |
DHR
| Danaher Corp | Mbwsqhfmp | Chnrp | $184.0 Bil | |
IQV
| IQVIA Holdings Inc | Xfcxlpn | Qvkql | $46.0 Bil | |
IDXX
| IDEXX Laboratories Inc | Zcrmzvvg | Tzbzlw | $44.8 Bil | |
A
| Agilent Technologies Inc | Mgvxndkq | Zgrd | $43.2 Bil | |
MTD
| Mettler-Toledo International Inc | Qwzcgzcv | Wmxybq | $28.6 Bil | |
ICLR
| Icon PLC | Fckdkrnfp | Cvhnzj | $27.2 Bil | |
ILMN
| Illumina Inc | Rmthrfl | Fdpfmk | $22.0 Bil | |
WAT
| Waters Corp | Hzlcycszb | Hvcq | $20.4 Bil | |
LH
| Laboratory Corp of America Holdings | Xvdrwvcf | Jnrdrb | $18.2 Bil |